WHO at the Global Hepatitis Summit 2023

25 – 28 April 2023
Paris, France and online

The 18th Global Hepatitis Summit (GHS 2023) will take place in Paris, France, from 25-28 April 2023. GHS 2023 is a networking and research conference designed to share the latest developments in all aspects of liver diseases, including basic science, translational research, development of novel diagnostic tools and therapies, and approaches to control and eliminate liver diseases as public health threats.

WHO participates in GHS 2023 with a number of sessions including a 2 hours symposium entitled Viral Hepatitis Elimination – What’s new, what’s next, what’s missing in WHO guidance. The aim of the symposium is to share latest updates on key recent developments in hepatitis policy and research and highlight regional and country experience from across the world.

Overview

24 April, 14:20 – 15:00 | Pre-conference: Hepatitis C Point of Care Testing Forum

26 April, 11:00 – 13:00 | Plenary 2: Public health interventions in liver diseases

26 April, 14:00 – 16:00 | Debate 1: Public health

27 April, 08:30 – 10:30 | WHO symposium

27 April, 16:30 – 18:30 | NoHep Medical Visionaries Symposium

WHO symposium

Thursday, 27 April 2023 – 08:30-10:30 (CET)

Viral Hepatitis Elimination: What’s new | What’s next | What’s missing in WHO guidance

Co-chairs: Professor Margaret Hellard, Deputy Director, Burnet Institute  & Head, Hepatitis Services, Department of Infectious Diseases, The Alfred Hospital, Melbourne, Australia & Dr Meg Doherty, Director of Global HIV, Hepatitis & STIs Programmes, WHO, Geneva.

Presentations

  • Setting the scene- evolving global perspective for hepatitis and highlights from the Global Health Sector Strategies on HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030
  • Next steps for measuring progress to viral hepatitis 2030 elimination targets 
  • What’s new and what’s next- Simplified service delivery for adults & children with hepatitis B and C 
  • Reaching hepatitis elimination in key populations and PWID 
  • Getting to person centered data, hepatitis cascade and mortality towards 2030 elimination 

The presentations will be followed by a 30 minute facilitated panel discussion focused on identifying what’s missing to reach the global elimination targets by 2030.